our technology

We do find the needle in the haystack.

Revolutionary solutions for cancer detection.

We do find the needle in the haystack.

Revolutionary solutions for cancer detection.

how it works.

All we need is a simple blood drop.

Every patient is different.That’s why we can count on the best-matching extraction method, depending on the specificity of the case.

Then, either we reduce the size of the ‘haystack’…

…Or we find the ‘needle’ with a potentiated ‘magnet’.

Either way, the result is what matters to us:
a better patient outcome.

TRADITIONAL biopsy vs LIQUID BIOBSY 2.0

Exosomics selectively isolates tumour-derived exosomes from biofluids and extracts their tumour-derived DNA and RNA content. Our technology allows earlier detection of tumour-causing mutations from liquid biopsies and enables the next generation of cancer detection, staging, profiling and monitoring tests.

Traditional Biopsy

Sampling cancer tissue

Invasive, time consuming, does not represent the whole tumour, cannot be used for monitoring, risk associated.

Traditional Biopsy

Sampling cancer tissue

Invasive, time consuming, does not represent the whole tumour, cannot be used for monitoring, risk associated.

Exosomics Liquid Biopsy

Liquid biopsy 2.0

Minimally invasive, cheaper, tumour heterogeneity detectable, better treatment indications, can be easily obtained and repeated, ideal for screening, staging, profiling and monitoring, easier for hard to reach tumours.
Can selectively isolate tumor-derived exosomes and analyse their content.

Let’s talk science.

We have developed a unique, patented technology to isolate tumor-derived vesicles and to utilise the information contained within.